HLS Therapeutics Inc. (HLS.TO)
CAD 3.62
(0.56%)
CAD 3.62
(0.56%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 65.66 Million USD | -14.29% |
| 2022 | 76.62 Million USD | 0.31% |
| 2021 | 76.38 Million USD | -11.7% |
| 2020 | 86.51 Million USD | 87.94% |
| 2019 | 46.03 Million USD | -46.34% |
| 2018 | 85.77 Million USD | -14.64% |
| 2017 | 100.48 Million USD | -16.88% |
| 2016 | 120.89 Million USD | -12.18% |
| 2015 | 137.66 Million USD | 393.29% |
| 2014 | -46.93 Million USD | -39.21% |
| 2013 | -33.71 Million USD | -34.38% |
| 2012 | -25.09 Million USD | -77.46% |
| 2011 | -14.13 Million USD | -46.91% |
| 2010 | -9.62 Million USD | -340.46% |
| 2009 | 4 Million USD | -13.16% |
| 2008 | 4.6 Million USD | 344.47% |
| 2007 | -1.88 Million USD | -116.28% |
| 2006 | 11.58 Million USD | 353.52% |
| 2005 | -4.56 Million USD | -174.23% |
| 2004 | 6.15 Million USD | 46835.12% |
| 2003 | 13.11 Thousand USD | 100.11% |
| 2002 | -11.63 Million USD | -13.11% |
| 2001 | -10.28 Million USD | -384.1% |
| 2000 | 3.61 Million USD | -62.56% |
| 1999 | 9.66 Million USD | 83.62% |
| 1998 | 5.26 Million USD | -34.5% |
| 1997 | 8.03 Million USD | 108.3% |
| 1996 | 3.85 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 50.55 Million USD | -23.0% |
| 2024 Q1 | 65.65 Million USD | -0.02% |
| 2023 FY | 65.66 Million USD | -14.29% |
| 2023 Q1 | 73.98 Million USD | -3.44% |
| 2023 Q2 | 73.14 Million USD | -1.14% |
| 2023 Q3 | 68.92 Million USD | -5.77% |
| 2023 Q4 | 65.66 Million USD | -4.72% |
| 2022 FY | 76.62 Million USD | 0.31% |
| 2022 Q2 | 70.47 Million USD | -2.07% |
| 2022 Q1 | 71.96 Million USD | -5.79% |
| 2022 Q3 | 78.42 Million USD | 11.28% |
| 2022 Q4 | 76.62 Million USD | -2.3% |
| 2021 Q1 | 81.76 Million USD | -5.49% |
| 2021 FY | 76.38 Million USD | -11.7% |
| 2021 Q3 | 78.29 Million USD | -3.91% |
| 2021 Q4 | 76.38 Million USD | -2.44% |
| 2021 Q2 | 81.48 Million USD | -0.34% |
| 2020 Q1 | 50.06 Million USD | 8.76% |
| 2020 Q4 | 86.51 Million USD | -1.9% |
| 2020 FY | 86.51 Million USD | 87.94% |
| 2020 Q3 | 88.18 Million USD | 54.99% |
| 2020 Q2 | 56.89 Million USD | 13.65% |
| 2019 Q1 | 83.7 Million USD | -2.42% |
| 2019 Q4 | 46.03 Million USD | 7.21% |
| 2019 FY | 46.03 Million USD | -46.34% |
| 2019 Q2 | 43.01 Million USD | -48.61% |
| 2019 Q3 | 42.93 Million USD | -0.17% |
| 2018 FY | 85.77 Million USD | -14.64% |
| 2018 Q1 | 76.73 Million USD | -23.63% |
| 2018 Q2 | 80.01 Million USD | 4.27% |
| 2018 Q3 | 87.91 Million USD | 9.87% |
| 2018 Q4 | 85.77 Million USD | -2.43% |
| 2017 FY | 100.48 Million USD | -16.88% |
| 2017 Q4 | 100.48 Million USD | -11.87% |
| 2017 Q3 | 114.02 Million USD | 556.55% |
| 2017 Q2 | -24.97 Million USD | -0.19% |
| 2017 Q1 | -24.92 Million USD | -120.62% |
| 2016 Q2 | -25.4 Million USD | 1.59% |
| 2016 Q3 | -25.93 Million USD | -2.07% |
| 2016 Q4 | 120.89 Million USD | 566.18% |
| 2016 FY | 120.89 Million USD | -12.18% |
| 2016 Q1 | -25.81 Million USD | -2.2% |
| 2015 Q4 | -25.26 Million USD | 5.13% |
| 2015 Q2 | -41.5 Million USD | 5.4% |
| 2015 FY | 137.66 Million USD | 393.29% |
| 2015 Q3 | -26.62 Million USD | 35.84% |
| 2015 Q1 | -43.87 Million USD | 6.53% |
| 2014 FY | -46.93 Million USD | -39.21% |
| 2014 Q1 | -35.96 Million USD | -6.66% |
| 2014 Q3 | -39.24 Million USD | -3.53% |
| 2014 Q4 | -46.93 Million USD | -19.6% |
| 2014 Q2 | -37.9 Million USD | -5.41% |
| 2013 Q3 | -33.77 Million USD | -13.06% |
| 2013 FY | -33.71 Million USD | -34.38% |
| 2013 Q4 | -33.71 Million USD | 0.17% |
| 2013 Q2 | -29.87 Million USD | -9.77% |
| 2013 Q1 | -27.21 Million USD | -8.47% |
| 2012 Q4 | -25.09 Million USD | -5.06% |
| 2012 Q3 | -23.88 Million USD | -63.31% |
| 2012 FY | -25.09 Million USD | -77.46% |
| 2012 Q2 | -14.62 Million USD | -5.41% |
| 2012 Q1 | -13.87 Million USD | 1.88% |
| 2011 Q3 | -9.4 Million USD | 21.83% |
| 2011 Q2 | -12.03 Million USD | 2.83% |
| 2011 Q1 | -12.38 Million USD | -28.69% |
| 2011 FY | -14.13 Million USD | -46.91% |
| 2011 Q4 | -14.13 Million USD | -50.3% |
| 2010 Q2 | -7.45 Million USD | -340.25% |
| 2010 Q3 | -5.98 Million USD | 19.72% |
| 2010 Q4 | -9.62 Million USD | -60.74% |
| 2010 Q1 | -1.69 Million USD | -142.33% |
| 2010 FY | -9.62 Million USD | -340.46% |
| 2009 Q4 | 4 Million USD | 626.23% |
| 2009 FY | 4 Million USD | -13.16% |
| 2009 Q1 | 4.37 Million USD | -5.08% |
| 2009 Q2 | 6.36 Million USD | 45.47% |
| 2009 Q3 | -760.59 Thousand USD | -111.95% |
| 2008 FY | 4.6 Million USD | 344.47% |
| 2008 Q4 | 4.6 Million USD | -50.37% |
| 2008 Q1 | 4.71 Million USD | 350.04% |
| 2008 Q2 | -8.06 Million USD | -271.1% |
| 2008 Q3 | 9.28 Million USD | 215.13% |
| 2007 Q4 | -1.88 Million USD | -140.36% |
| 2007 Q2 | 7.39 Million USD | -15.81% |
| 2007 Q1 | 8.77 Million USD | -24.19% |
| 2007 FY | -1.88 Million USD | -116.28% |
| 2007 Q3 | 4.67 Million USD | -36.79% |
| 2006 FY | 11.58 Million USD | 353.52% |
| 2006 Q4 | 11.58 Million USD | 60.31% |
| 2006 Q3 | 7.22 Million USD | 143.83% |
| 2006 Q2 | 2.96 Million USD | 72.01% |
| 2006 Q1 | 1.72 Million USD | 137.71% |
| 2005 Q4 | -4.56 Million USD | -165.75% |
| 2005 Q3 | 6.94 Million USD | 909.75% |
| 2005 Q2 | -857.93 Thousand USD | -114.3% |
| 2005 Q1 | 6 Million USD | -2.47% |
| 2005 FY | -4.56 Million USD | -174.23% |
| 2004 Q1 | -2.42 Million USD | -18581.57% |
| 2004 FY | 6.15 Million USD | 46835.12% |
| 2004 Q3 | 1.23 Million USD | 222.1% |
| 2004 Q2 | -1.01 Million USD | 58.27% |
| 2004 Q4 | 6.15 Million USD | 398.42% |
| 2003 Q4 | 13.11 Thousand USD | -99.52% |
| 2003 FY | 13.11 Thousand USD | 100.11% |
| 2003 Q1 | -1.37 Million USD | 88.19% |
| 2003 Q2 | -2.04 Million USD | -48.58% |
| 2003 Q3 | 2.75 Million USD | 235.13% |
| 2002 Q4 | -11.63 Million USD | -9.06% |
| 2002 Q1 | -9.27 Million USD | 9.83% |
| 2002 Q2 | -10.74 Million USD | -15.88% |
| 2002 Q3 | -10.66 Million USD | 0.74% |
| 2002 FY | -11.63 Million USD | -13.11% |
| 2001 FY | -10.28 Million USD | -384.1% |
| 2001 Q1 | 2.88 Million USD | -20.28% |
| 2001 Q2 | -8.55 Million USD | -396.55% |
| 2001 Q3 | -10.41 Million USD | -21.68% |
| 2001 Q4 | -10.28 Million USD | 1.23% |
| 2000 Q3 | - USD | 0.0% |
| 2000 FY | 3.61 Million USD | -62.56% |
| 2000 Q1 | - USD | -100.0% |
| 2000 Q4 | 3.61 Million USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 FY | 9.66 Million USD | 83.62% |
| 1999 Q1 | - USD | -100.0% |
| 1999 Q4 | 9.66 Million USD | 0.0% |
| 1998 FY | 5.26 Million USD | -34.5% |
| 1998 Q4 | 5.26 Million USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 FY | 8.03 Million USD | 108.3% |
| 1997 Q1 | - USD | 0.0% |
| 1996 FY | 3.85 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | -8.64 Million CAD | 859.355% |
| Avicanna Inc. | 1.32 Million CAD | -4851.67% |
| Avant Brands Inc. | 17.93 Million CAD | -266.252% |
| Cardiol Therapeutics Inc. | -34.77 Million CAD | 288.849% |
| Crescita Therapeutics Inc. | -8.13 Million CAD | 907.637% |
| Knight Therapeutics Inc. | 10.33 Million CAD | -535.712% |
| MediPharm Labs Corp. | -15.68 Million CAD | 518.647% |
| OrganiGram Holdings Inc. | -33.7 Million CAD | 294.811% |
| Canopy Growth Corporation | 512.87 Million CAD | 87.196% |
| Willow Biosciences Inc. | -989 Thousand CAD | 6739.939% |
| Auxly Cannabis Group Inc. | 142.88 Million CAD | 54.039% |